BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16359516)

  • 1. Persistent production of platelet thromboxane A2 in patients chronically treated with aspirin.
    Pulcinelli FM; Riondino S; Celestini A; Pignatelli P; Trifirò E; Di Renzo L; Violi F
    J Thromb Haemost; 2005 Dec; 3(12):2784-9. PubMed ID: 16359516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of biological relevance of platelet cyclooxygenase-2 dependent thromboxane A2 production.
    Riondino S; Trifirò E; Principessa L; Mascioletti S; Di Renzo L; Gaudio C; Biasucci LM; Crea F; Pulcinelli FM
    Thromb Res; 2008; 122(3):359-65. PubMed ID: 18295304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thromboxane (Tx) A2 receptor blockade and TxA2 synthase inhibition alone and in combination: comparison of anti-aggregatory efficacy in human platelets.
    Watts IS; Wharton KA; White BP; Lumley P
    Br J Pharmacol; 1991 Feb; 102(2):497-505. PubMed ID: 1826620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin and the in vitro linear relationship between thromboxane A2-mediated platelet aggregation and platelet production of thromboxane A2.
    Armstrong PC; Truss NJ; Ali FY; Dhanji AA; Vojnovic I; Zain ZN; Bishop-Bailey D; Paul-Clark MJ; Tucker AT; Mitchell JA; Warner TD
    J Thromb Haemost; 2008 Nov; 6(11):1933-43. PubMed ID: 18752570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure of aspirin to impair bovine platelet function.
    Gentry PA; Tremblay RR; Ross ML
    Am J Vet Res; 1989 Jun; 50(6):919-22. PubMed ID: 2764343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological efficacy of low against medium dose aspirin regimen after coronary surgery: analysis of platelet function.
    Cornelissen J; Kirtland S; Lim E; Goddard M; Bellm S; Sheridan K; Large S; Vuylsteke A
    Thromb Haemost; 2006 Mar; 95(3):476-82. PubMed ID: 16525576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of thromboxane A2 in increased whole blood platelet aggregation in oral contraceptive users.
    Norris LA; Devitt M; Bonnar J
    Thromb Res; 1996 Feb; 81(4):407-17. PubMed ID: 8907290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of platelet cytosolic phospholipase A2 activity by atorvastatin and simvastatin: biochemical regulatory mechanisms.
    Moscardó A; Vallés J; Latorre A; Madrid I; Santos MT
    Thromb Res; 2013 Apr; 131(4):e154-9. PubMed ID: 23352311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin resistance detected with aggregometry cannot be explained by cyclooxygenase activity: involvement of other signaling pathway(s) in cardiovascular events of aspirin-treated patients.
    Ohmori T; Yatomi Y; Nonaka T; Kobayashi Y; Madoiwa S; Mimuro J; Ozaki Y; Sakata Y
    J Thromb Haemost; 2006 Jun; 4(6):1271-8. PubMed ID: 16706971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition by picotamide of thromboxane production in vitro and ex vivo.
    Violi F; Ghiselli A; Iuliano L; Praticò D; Alessandri C; Balsano F
    Eur J Clin Pharmacol; 1988; 33(6):599-602. PubMed ID: 3366163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Habitual smoking causes an abnormality in platelet thromboxane A2 metabolism and results in an altered susceptibility to aspirin effects.
    Weber AA; Liesener S; Schanz A; Hohlfeld T; Schrör K
    Platelets; 2000 May; 11(3):177-82. PubMed ID: 10938895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COX-1 sensitivity and thromboxane A2 production in type 1 and type 2 diabetic patients under chronic aspirin treatment.
    Pulcinelli FM; Biasucci LM; Riondino S; Giubilato S; Leo A; Di Renzo L; Trifirò E; Mattiello T; Pitocco D; Liuzzo G; Ghirlanda G; Crea F
    Eur Heart J; 2009 May; 30(10):1279-86. PubMed ID: 19346231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose Aspirin prevents hypertension and cardiac fibrosis when thromboxane A
    D'Agostino I; Tacconelli S; Bruno A; Contursi A; Mucci L; Hu X; Xie Y; Chakraborty R; Jain K; Sacco A; Zucchelli M; Landolfi R; Dovizio M; Falcone L; Ballerini P; Hwa J; Patrignani P
    Pharmacol Res; 2021 Aug; 170():105744. PubMed ID: 34182131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thromboxane A(2) generation, in the absence of platelet COX-1 activity, in patients with and without atherothrombotic myocardial infarction.
    DeFilippis AP; Oloyede OS; Andrikopoulou E; Saenger AK; Palachuvattil JM; Fasoro YA; Guallar E; Blumenthal RS; Kickler TS; Jaffe AS; Gerstenblith G; Schulman SP; Rade JJ
    Circ J; 2013; 77(11):2786-92. PubMed ID: 23985963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet hypersensitivity in cholesterol-fed rabbits: enhancement of thromboxane A2-dependent and thrombin-induced, thromboxane A2-independent platelet responses.
    Gross PL; Rand ML; Barrow DV; Packham MA
    Atherosclerosis; 1991 May; 88(1):77-86. PubMed ID: 1878012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for a role in thrombus stabilization for thromboxane A2 in human platelet deposition on collagen.
    Wagner WR; Hubbell JA
    J Lab Clin Med; 1992 Jun; 119(6):690-7. PubMed ID: 1534345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thromboxane A2 synthase inhibition and thromboxane A2 receptor blockade by 2-[(4-cyanophenyl)amino]-3-chloro-1,4-naphthalenedione (NQ-Y15) in rat platelets.
    Chang TS; Kim HM; Lee KS; Khil LY; Mar WC; Ryu CK; Moon CK
    Biochem Pharmacol; 1997 Jul; 54(2):259-68. PubMed ID: 9271330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Difference of (Ca2+)i movements in platelets stimulated by thrombin and TRAP: the involvement of alpha(IIb)beta3-mediated TXA2 synthesis.
    Aoki T; Tomiyama Y; Honda S; Senzaki K; Tanaka A; Okubo M; Takahashi F; Takasugi H; Seki J
    Thromb Haemost; 1998 Jun; 79(6):1184-90. PubMed ID: 9657446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De novo synthesis of cyclooxygenase-1 counteracts the suppression of platelet thromboxane biosynthesis by aspirin.
    Evangelista V; Manarini S; Di Santo A; Capone ML; Ricciotti E; Di Francesco L; Tacconelli S; Sacchetti A; D'Angelo S; Scilimati A; Sciulli MG; Patrignani P
    Circ Res; 2006 Mar; 98(5):593-5. PubMed ID: 16484611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cumulative inhibitory effect of low-dose aspirin on vascular prostacyclin and platelet thromboxane production in patients with atherosclerosis.
    Weksler BB; Tack-Goldman K; Subramanian VA; Gay WA
    Circulation; 1985 Feb; 71(2):332-40. PubMed ID: 3880671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.